Urinary proteins with pro-apoptotic and antitumor activity

Apoptosis

Volumn 5, Issue 1, 2000, Pages 21-28

  Pati, Shibani ^a,b   Lee, Young ^b   Samaniego, Felipe ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Angiogenesis; Endothelial; hCG associated factor HAF ; Human chorionic gonadotropin hCG

Indexed keywords

ACTIVIN A; ANGIOSTATIN; ANTINEOPLASTIC URINARY PROTEIN; CHORIONIC GONADOTROPIN; ENDOSTATIN; EOSINOPHIL PROTEIN X; INHIBIN; PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; ENDOTHELIUM CELL; KAPOSI SARCOMA; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; URINE;

ANGIOSTATINS; ANTIGENS, LY; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHORIONIC GONADOTROPIN; COLLAGEN; ENDOSTATINS; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; HUMANS; PEPTIDE FRAGMENTS; PLASMINOGEN; PREGNANCY; PREGNANCY PROTEINS; PROTEINS; RIBONUCLEASES; SARCOMA, KAPOSI; URINARY PLASMINOGEN ACTIVATOR; URINE;

EID: 0034116030     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009629424297     Document Type: Article

References (70)

1. Edwards JJ, Tollaksen SL, Anderson NG. Proteins of human urine. III. Identification and two-dimensional electrophoretic map positions of some major urinary proteins. Clin Chem 1982; 28: 941-948.
2. Rasmussen HH, Orntoft TF, Wolf H, Celis JE. Towards a comprehensive database of proteins from urine of patients with bladder cancer. J Urol 1996; 1555: 113-2119.
3. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-821.
4. Cathomas G, Tamm M, McGandy CE, et al. Transplantation-associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma. Transplantation 1997; 64: 175-178.
5. Safai B, Johnson KG, Myskowski PL, et al. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 744-750.
6. Mitsuyasu RT. Clinical aspects of AIDS-related Kaposi's sarcoma. Curr Opin Oncol 1993; 5: 835-844.
7. McNutt NS, Fletcher V, Conant MA. Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am J Pathol 1983; 111: 62-77.
8. Nadji M, Morales AR, Ziegles-Weissman J, Penneys NS. Kaposi's sarcoma: immunohistologic evidence for an endothelial origin. Arch Pathol Lab Med 1981; 105: 274-275.
9. Roth WK, Werner S, Risau W, Remberger K, Hofschneider PH. Cultured, AIDS-related Kaposi's sarcoma cells express endothehal cell markers and are weakly malignant in vitro. Int J Cancer 1988; 42: 767-773.
10. Regezi JA, MacPhail LA, Daniels TE, DeSouza YG, Greenspan JS, Greenspan D. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol 1993; 143: 240-249.
11. Fan J, Bass HZ, Fahey JL. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993; 151: 5031-5040.
12. Samaniego F, Markham PD, Gallo RC, Ensoli B. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol 1995; 154: 3582-3592.
13. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 1997; 94: 979-984.
14. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 1997; 158: 1887-1894.
15. Samaniego F, Gallo RC. Immunopathogenesis of Kaposi's sarcoma. In: Gupta S, ed. Immunology of HIV Infection. New York: Plenum 1996: 437-450.
16. Cesarman E, Nador RG, Bai F, et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996; 70: 8218-8223.
17. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862-14867.
18. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739-1744.
19. Cheng EH, Nicholas J, Bellows DS, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997; 94: 690-694.
20. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998; 391: 86-89.
21. Davis MA, Sturzl MA, Blasig C, et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1997; 89: 1868-1874.
22. Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 1998; 4: 435-440.
23. Siegel B, Levintin-Kriss S, Schiffer A, Sayer J, Engelberg I, Vonsover A, et al. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer 1990; 65: 492-498.
24. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 75: 64-68.
25. Hermans P. AIDS-related Kaposi's sarcoma patients with visceral manifestations: Response to human chorionic gonadotropin preparations. J Hum Virol 1998; 1: 82-89.
26. Gill PS, Lunardi-Ishkandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 1996; 335: 1261-1269. (Published errata appear in N Engl J Med 1997; 336: 670 and 1997; 336: 1115).
27. Lunardi-Iskandar Y, Bryant JL, Blattner WA, et al. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med 1998; 4: 428-434.
28. Morse JH, Lustbader JW, Harrington JW, Canfield RE. Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting. Am J Reprod Immunol Microbiol 1988; 17: 134-140.
29. Rabkin CS, Chibwe G, Muyunda K, Musaba E. Kaposi's sarcoma in pregnant women [letter]. Nature 1995; 377: 21-22.
30. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1995; 4: 437-440.
31. Samaniego F, Bryant JL, Liu N, et al. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin.J Natl Cancer Inst 1999; 91: 135-143.
32. Hermeking H, Eick D. Mediation of c-myc-induced apoptosis by p53. Science 1994; 265: 2091-2093.
33. Albini A, Paglieri I, Orengo G, et al. The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 1997; 11: 713-721.
34. Yoshimura M, Nishikawa M, Mori Y, et al. Human chorionic gonadotropin induces c-myc mRNA expression via TSH receptor in FRTL-5 rat thyroid cells. Thyroid 1992; 2: 315-319.
35. Gillott DJ, Iles RK, Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 1996; 73: 323-326.
36. Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 1995; 181: 1109-1177.
37. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ, Giaccia AJ. Modulation of c-Myc activity and apoptosis in vivo. Cancer Res 1996; 56: 4315-4319.
38. Kachra Z, Guo WX, Sairam MR, Antakly T. Low molecular weight components but not dimeric HCG inhibit growth and down-regulate AP-1 transcription factor in Kaposi's sarcoma cells. Endocrinology 1997; 138: 4038-4041.
39. Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res 1998; 18: 4003-4010.
40. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 1990; 82: 1286-1289.
41. Srivastava P, Silva ID, Russo J, Mgbonyebi OP, Russo IH. Identification of new genes differentially expressed in breast carcinoma cells treated with human chorionic gonadotropin. Int J Oncol 1998; 13: 465-469.
42. Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 1997; 18: 1799-1808.
43. Feldman EJ, Seiter K, Chiao JW, et al. In vitro effects and clinical evaluation of a human chorionic gonadotrophin preparation in acute leukemia. Leukemia 1998; 12: 1749-1755.
44. Gallo RC, Lunardi-Iskandar Y, Bryant J, Birken S. Mysterious anti-KS activity still a mystery. Nature Medicine 1998; 4: 2.
45. Lang ME, Lottersberger C, Roth B, et al. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. AIDS 1997; 11: 1333-1340.
46. Keutmann HT, Charlesworth MC, Mason KA, Ostrea T, Johnson L, Ryan RJ. A receptor-binding region in human choriogonadotropin/lutropin beta subunit. Proc Natl Acad Sci USA 1987; 84: 2038-2042.
47. Griffiths SJ, Adams DJ, Talbot SJ. Ribonuclease inhibits Kaposi's sarcoma [letter]. Nature 1997; 390: 568.
48. Newton DL, Rybak SM. Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth. J Natl Cancer Inst 1998; 90: 1787-1791.
49. Newton DL, Xue Y, Boque L, Wlodawer A, Kung HF, Rybak SM. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy. Protein Eng 1997; 10: 463-470.
50. Wu Y, Mikulski SM, Ardelt W, Rybak SM, Youle RJ. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity. J Biol Chem 1993; 268: 10686-10693.
51. Mikulski SM, Viera A, Deptala A, Darzynkiewicz Z. Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor. Int J Oncol 1998; 13: 633-644.
52. Juan G, Ardelt B, Li X, et al. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation. Leukemia 1998; 12: 1241-1248.
53. Darzynkiewicz Z. The butler did it: search for killer(s) of Kaposi's sarcoma cells in preparations of human chorionic gonadotropin [editorial]. J Natl Cancer Inst 1999; 91:104-106.
54. Sloane NH, Lynn WR, Macleod RM, Hade EP, Pottathil R, Kyriazis AP. Studies on an antineoplastic fraction from human urine. Characterization of the major protein in this fraction. Biochem J 1986; 234: 355-362.
55. Ridge RJ, Sloane NH. Partial N-terminal amino acid sequence of the anti-neoplastic urinary protein (ANUP) and the antitumour effect of the N-terminal nonapeptide of the unique cytokine present in human granulocytes. Cytokine 1996; 8: 1-5.
56. Masood R, McGarvey ME, Zheng T, et al. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood 1999; 93: 1038-1044.
57. Folkman J. Tumor angiogenesis. Adv Cancer Res 1974; 19: 331-358.
58. Folkman J. Clinical applications of research on angiogenesis. [Seminars in Medicine of the Beth Israel Hospital, Boston]. N Engl J Med 1995; 333: 1757-1763.
59. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
60. Clark WH, Jr., Elder DE, Guerry D 4th, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893-1904.
61. Claesson-Welsh L, Welsh M, Ito N, et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998; 95: 5579-5583.
62. Lucas R, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998; 92: 4730-4741.
63. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
64. Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999; 274: 11721-11726.
65. Petraglia F, Zanin E, Faletti A, Reis FM. Inhibins: paracrine and endocrine effects in female reproductive function. Curr Opin Obstet Gynecol 1999; 11: 241-247.
66. Wang EY, Draper LB, Lee E, et al. Identification of naturally occurring follistatin complexes in human biological fluids. Biol Reprod 1999; 60: 8-13.
67. Jenkin G, McFarlane J, de Kretser DM. Inhibin and activin in embryonic and fetal development in ruminants. J Reprod Fertil [Suppl] 1995; 49: 177-186.
68. Nishihara T, Okahashi N, Ueda N. Activin A induces apoptotic cell death. Biochem Biophys Res Commun 1993; 197: 985-991.
69. Wang QF, Tilly KI, Tilly JL, et al. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology 1996; 137: 5476-5483.
70. Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99: 2139-2151.